, C(16)-C(15)-H(15B)
, H(1A)-C(1)-H(1B)
, C(13)-C(12)-H(12A)
,
,
, H(12C)-C(12')-H(12D)
H(33A) used to generate equivalent atoms: Anisotropic displacement parameters (Å 2 x 10 3 ). The anisotropic displacement factor exponent takes the form:-2 pi 2, vol.84, p.15 ,
, , vol.18, p.17
, , vol.46, pp.10-15
, C(12')-C(13') 1.547(14)
, C, issue.27
, C(12')-C(13'), vol.113
,
,
,
, H(13C)-C(13')-H(13D)
, C(28)-C(27)-H(27)
, C(27')-C(26')-C(24), vol.116
, C(24)-C(26')-H(26C), vol.108
, C(24)-C(26')-H(26D), vol.108
, H(26C)-C(26')-H(26D), vol.107
, C(28')-C(27')-C(26'), vol.125
, C(28')-C(27')-H(27'), vol.117
, C(26')-C(27')-H(27'), vol.117
, C(27')-C(28')-C(29'), vol.126
, C(27')-C(28')-H(28') 116
, C(29')-C(28')-H(28') 116
, C(30')-C(29')-C(28'), vol.127
, C(30')-C(29')-H(29'), vol.116
, C(28')-C(29')-H(29'), vol.116
, C(29')-C(30')-C(31') 124, vol.8
, C(29')-C(30')-H(30') 117
, C(31')-C(30')-H(30') 117
, C(30')-C(31')-C(32'), vol.111
,
,
,
, H(32C)-C(32')-H(32D)
, O(1)-H(1A) equivalent atoms: (1) www.cervco.fr/fr/maladie/questions-frequentes
,
Circulation 1995, 92, 1355 ; dx, Médecine Nucléaire-Imagerie fonctionnelle et métabolique 2005, vol.29, pp.198-202 ,
,
Arteriosclerosis, Thrombosis, and Vascular Biology 1995, 15, 1512 ; dx, Bonnet J. ; EMC-Cardiologie-Angéiologie, vol.2, issue.5, pp.436-458, 2005. ,
,
, , vol.409, pp.41-50, 2009.
, Vascular Pharmacology, vol.38, pp.259-269, 2002.
,
, Antioxydants & Redox Signaling, vol.20, issue.9, pp.1126-1167, 2014.
, Postgraduate Medical Journal, vol.902, issue.10, pp.144-150, 2000.
, , vol.17, pp.387-392, 2008.
, Journal of Molecular and Cellular Cardiology, vol.31, issue.14, pp.23-37, 1999.
, Autoimmunity Reviews, vol.9, issue.15, pp.830-834, 2010.
, Superville A. : Nouvelles voies de régulation contrôlant l'homéostasie lipidique et l'inflammation dans le macrophage humain au cours de l'athérosclérose
, , vol.109, 2004.
, Proceedings of the National Academy of Sciences of the United States of America, vol.29, pp.3-6, 1986.
, Molecules and Cells, vol.37, issue.21, pp.435-440, 2014.
, Vascular Pharmacology, vol.82, issue.22, pp.1-10, 2016.
, Biochimie, vol.13, issue.23, pp.281-296, 1982.
, Nature reviews. Immunology, vol.13, issue.26, pp.709-721, 2013.
, Nature reviews. Cardiology, vol.7, issue.27, pp.77-86, 2010.
, Current Opinion in Cell Biology, vol.7, issue.28, pp.714-723, 1996.
, Internal Medicine Journal, vol.33, pp.380-386, 2003.
, Clinica Chimica Acta, vol.26, issue.32, pp.245-252, 2007.
, 34) Bobryshev V. ; Micron, vol.37, pp.208-222, 2006.
, Progress in Lipid Research, vol.64, issue.36, pp.117-122, 2011.
, Circulation Research, vol.118, p.692, 2016.
, European Journal of Medicinal Chemistry, vol.20, issue.39, pp.295-312, 1262.
, 43) Carocho M., Ferreira I. C. ; Food and Chemical Toxicology, vol.51, pp.15-25, 2013.
, European Journal of Medicinal Chemistry, vol.97, issue.44, pp.55-74, 2015.
, Vascular Pharmacology, vol.71, issue.45, pp.40-56, 2015.
, Food Research International, vol.74, issue.46, pp.10-36, 2015.
, Current pharmaceutical biotechnology, vol.22, issue.47, pp.307-313, 2000.
Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence 2012, Oxidative Medicine and Cellular Longevity, vol.3, issue.54, pp.228-237, 2010. ,
, Toxicology Letters, vol.159, pp.1-12, 2005.
59) Mallat Z., Tedgui A. ; Le Courrier de l'Arcol et de la SFA, Journal of Medicinal Chemistry, vol.24, issue.57, pp.62-74, 2001. ,
, Nature Reviews, Drug Discovery, vol.7, issue.63, pp.1409-1438, 2008.
, Chemico-Biological Interactions, vol.174, issue.65, pp.27-37, 2008.
, Angewandte Chemie International Edition, vol.51, issue.66, pp.5308-5332, 2012.
, Biochemical Pharmacology, vol.75, issue.67, pp.787-809, 2008.
,
, BioFactors, 2016.
, , vol.4, pp.10815-10829, 2014.
, Tetrahedron Letters, vol.12, pp.3741-3746, 1971.
, Bioorganic & Medicinal Chemistry Letters, vol.26, pp.3248-3251, 1987.
,
, Chemistry & Biodiversity, vol.9, issue.76, pp.1475-1489, 2012.
, Biological and Pharmaceutical Bulletin, vol.51, issue.79, pp.4026-4029, 2003.
, The Journal of Organic Chemistry, vol.77, pp.914-924, 1976.
, Organic Letters, vol.19, issue.85, pp.1804-1807, 2017.
, The Journal of Organic Chemistry, vol.57, issue.86, pp.1744-1752, 1992.
, Tetrahedron Letters, vol.87, pp.735-738, 1996.
, Organic preparations and procedures international 2013, vol.119, pp.13832-13840, 1901.
,
(97) Cohen T., Cristea I, Journal of the American Chemical Society, vol.45, pp.748-753, 1976. ,
(99) Paine J, Journal of the American Chemical Society, vol.92, pp.1496-1502, 1970. ,
, Journal of the American Chemical Society, vol.132, issue.100, pp.3624-3626, 1964.
, Tetrahedron Letters, vol.53, issue.103, pp.4173-4178, 2012.
, Bioorganic & Medicinal Chemistry Letters, vol.22, issue.104, pp.2103-2105, 2008.
, SCH-Models in chemistry, vol.58, pp.2394-2395, 1974.
, Tetrahedron Letters, vol.17, issue.112, pp.2455-2458, 1976.
, Journal of the American Chemical Society, vol.78, issue.113, pp.137-148, 2005.
, Journal of Medicinal Chemistry, vol.67, issue.118, pp.9427-9440, 1967.
Pyrazinecarboxamide derivativesas epithelial sodium channel inhibitors and their preparation, pharmaceutical compositions and use for the treatment of cysticfibrosis and other chronic diseases, Journal of Organometallic Chemistry, vol.60, issue.121, pp.4225-4228, 1988. ,
, Tetrahedron, vol.61, issue.124, pp.1459-1480, 2005.
, Bioorganic & Medicinal Chemistry, vol.17, issue.125, pp.830-847, 2009.
, Organic Letters, vol.4, issue.126, pp.3001-3003, 2002.
, The Journal of Organic Chemistry, vol.66, issue.127, pp.2691-2694, 2001.
, Chemistry-A European Journal, vol.123, pp.7219-7232, 1999.
, Organic Letters, vol.16, issue.136, pp.1642-1645, 2014.
, Organic Letters, vol.15, issue.137, pp.1148-1151, 2013.
, Bioorganic & Medicinal Chemistry Letters, vol.22, issue.138, pp.874-877, 2012.
, Journal of the American Chemical Society, vol.130, issue.140, pp.4540-4543, 2008.
, The Journal of Organic Chemistry, vol.64, issue.143, pp.914-924, 1999.
, Journal of the American Chemical Society, vol.104, issue.144, pp.3303-3309, 1982.
, WO 2007117482, vol.94, pp.1327-1328, 1913.
, Bioorganic & Medicinal Chemistry Letters, vol.22, issue.153, pp.1346-1348, 2002.
, Nature Reviews : Neuroscience, vol.78, issue.155, pp.553-564, 1950.
, Journal of Steroid Biochemistry, vol.169, issue.159, pp.871-875, 1987.
, Journal of the American Chemical Society, vol.72, issue.162, pp.12809-12818, 2004.
, Bioorganic Chemistry, vol.71, issue.163, pp.30-54, 2017.
, Bioorganic & Medicinal Chemistry Letters, vol.12, issue.164, pp.3821-3839, 2005.
, Journal of Medicinal Chemistry, vol.111, issue.167, pp.6557-6602, 1994.
, Chemical Society Reviews, vol.38, issue.169, pp.606-631, 2009.
, Advanced Synthesis & Catalysis, vol.357, pp.5902-5905, 1993.
, Journal of the American Chemical Society, vol.113, issue.175, pp.1763-1767, 1991.
(178) Elamari H. ; Etudes sur la catalyse de la réaction de Huisgen et nouvelles applications synthétiques, Angewandte Chemie, vol.62, issue.177, pp.565-598, 1963. ,
, Chemical Communications, pp.2450-2451, 2003.
, Angewandte Chemie International Edition, vol.67, issue.181, pp.2596-2599, 2002.
, Bioorganic & Medicinal Chemistry Letters, vol.41, issue.183, pp.270-276, 2010.
, The Journal of Organic Chemistry, vol.77, pp.271-277, 1986.
Synthetic progress toward parvistemonine, spiroxins A and B, and generation of palmarumycin analogues, The Journal of Organic Chemistry, vol.25, issue.188, pp.4537-4538, 0191. ,
, Journal of Medicinal Chemistry, vol.39, pp.1664-1675, 1996.
, Organic Letters, vol.4, pp.2621-2623, 2002.
, Journal of the American Chemical Society, vol.11, issue.193, pp.1136-1139, 2010.
,